from

“Invisible millions” with hearing loss missing from mainstream media

New global research reveals a major media blind spot: Many people are unable to recall seeing anyone wearing a hearing device…

1 day ago

Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity

-- -18.8% placebo-adjusted difference in BMI reduction achieved in all patients (N=142) at 52 weeks, including 12 Japanese patients and…

3 days ago

DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting

Châtillon, France, February 28, 2026 DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026…

3 days ago

Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting

February 28, 2026 09:45 ET  | Source: Cogent Biosciences, Inc. Bezuclastinib mean TSS reduction deepens to –32.0 points at 48…

3 days ago

A Decade of India’s Evolving Naval Diplomacy: From SAGAR to MAHASAGAR

NEW DELHI, Feb. 26, 2026 /PRNewswire/ -- Over the past decade, the Indian Navy and India's maritime philosophy have undergone one…

5 days ago

Bank of Baroda, with support from Rocky Mountain Institute, and Climate Policy Initiative Launch Guidebook to Help Indian Banks Assess Corporate Transition Readiness

New guidebook provides practical guidance for Indian financial institutions to evaluate climate transition risks and opportunities in hard-to-abate sectors such…

6 days ago

From Minds to Machines: India’s top CEOs and CHROs chart the AI-Led talent blueprint at ET NexTech Human Capital Summit 2026

NEW DELHI, Feb. 25, 2026 /PRNewswire/ -- The Economic Times NexTech Human Capital Summit 2026, held on February 18-19, 2026,…

1 week ago

Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026

February 23, 2026 17:10 ET  | Source: Kyntra Bio FG-3246 and enzalutamide combination therapy, in biomarker unselected patients with androgen…

1 week ago

Not sure how to give wishes for the Year of the Horse? Let’s hear from CGs in Guangzhou

GUANGZHOU, China, Feb. 20, 2026 /PRNewswire/ -- A news report from South:   As we gallop into the Year of…

2 weeks ago

A taste of Chinese New Year in Guangdong: top picks from Consuls General in Guangzhou

GUANGZHOU, China, Feb. 20, 2026 /PRNewswire/ -- A news report from South: It's the Year of the Horse, and across Guangdong,…

2 weeks ago